BioVie
BIVI
15 hedge funds and large institutions have $1.6M invested in BioVie in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
7% more funds holding
Funds holding: 14 → 15 (+1)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
0.02% less ownership
Funds ownership: 0.06% → 0.04% (-0.02%)
78% less capital invested
Capital invested by funds: $7.14M → $1.6M (-$5.54M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
S
swisspartners
Vaduz,
Liechtenstein
|
+$242K |
| 2 |
Renaissance Technologies
New York
|
+$48K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$43.5K |
| 4 |
VF
Virtu Financial
New York
|
+$39.9K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$15K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KC
Kepos Capital
New York
|
-$1.62M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$10K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$5.4K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$2.1K |
| 5 |
BlackRock
New York
|
-$300 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $910K | +$43.5K | +145 | +2% |
|
|
S
2
swisspartners
Vaduz,
Liechtenstein
| $241K | +$242K | +805 | +100% |
|
3
Vanguard Group
Malvern,
Pennsylvania
| $238K | – | – | – |
|
|
4
Geode Capital Management
Boston,
Massachusetts
| $57K | +$15K | +50 | +15% |
|
|
KC
5
Kepos Capital
New York
| $36K | -$1.62M | -5,400 | -96% |
|
|
LFCM
6
Long Focus Capital Management
San Juan,
Puerto Rico
| $29K | – | – | – |
|
|
7
Renaissance Technologies
New York
| $23K | +$48K | +160 | New |
|
8
State Street
Boston,
Massachusetts
| $22K | – | – | – |
|
|
VF
9
Virtu Financial
New York
| $19K | +$39.9K | +133 | New |
|
|
10
BlackRock
New York
| $14K | -$300 | -1 | -1% |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| $6K | +$10.2K | +34 | +425% |
|
12
Wells Fargo
San Francisco,
California
| $4K | – | – | – |
|
13
Morgan Stanley
New York
| $2K | – | – | – |
|
|
14
Bank of America
Charlotte,
North Carolina
| – | -$10K | -22 | Closed |
|
|
15
UBS Group
Zurich,
Switzerland
| – | -$5.4K | -18 | -86% |
|
|
16
Osaic Holdings
Scottsdale,
Arizona
| – | -$2.1K | -7 | -70% |
|
BIVI Hedge Fund Activity: Q2 2022 in Review
15 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in BioVie (BIVI) for Q2 2022, worth a combined $1.6M — down 78% from $7.14M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new BIVI positions and 1 closed out — a net gain of 1 holder — while 4 added to existing stakes and 4 trimmed.
The largest buyer was swisspartners, adding an estimated $242K. The largest seller was Kepos Capital, cutting an estimated $1.62M.
- 15 institutional investors held BioVie (BIVI) as of Q2 2022, up from 14 in Q1 2022.
- Funds reported $1.6M of BioVie stock for Q2 2022, down 78% quarter-over-quarter.
- 2 funds opened new BioVie positions in Q2 2022 and 1 closed out, a net change of +1 holder.
- The largest BioVie buyer in Q2 2022 was swisspartners, an estimated $242K added.
- The largest BioVie seller in Q2 2022 was Kepos Capital, an estimated $1.62M sold.
Based on aggregated 13F filings for Q2 2022.